论文部分内容阅读
目的探究布地奈德联合沙丁胺醇氧驱动治疗喘憋性肺炎痰堵的临床效果。方法选择90例喘憋性肺炎患儿,随机分为两组,即观察组给予布地奈德联合沙丁胺醇氧驱动治疗,对照组给予常规治疗,再对比两组疗效。结果观察组肺部喘鸣音消失时间为(5.2±1.2)d,喘憋消失时间为(5.3±0.8)d,咳嗽消失时间为(5.2±1.1)d,住院时间为(7.6±1.4)d均显著短于对照组,具有统计学差异,P<0.05;治疗后观察组总有效率为97.8%显著高于对照组,具有统计学差异,P<0.05。结论喘憋性肺炎患儿采用布地奈德联合沙丁胺醇氧驱动治疗结合综合护理,可有效缓解患儿痰堵,改善临床症状,缩短病程,疗效确切,值得临床推广应用。
Objective To investigate the clinical efficacy of budesonide combined with salbutamol for the treatment of phlegm blocking of asthmatic pneumonia. Methods Ninety children with asthmatic pneumonia were selected and randomly divided into two groups. The observation group was treated with budesonide combined with salbutamol and the control group was given routine treatment. The curative effect was compared between the two groups. Results The disappearance time of pulmonary wheeze was (5.2 ± 1.2) days in the observation group, (5.3 ± 0.8) days in the asthmatic group, (5.2 ± 1.1) days in the cough disappear, and (7.6 ± 1.4) days in the observation group (P <0.05). After treatment, the total effective rate in the observation group was 97.8%, which was significantly higher than that in the control group, with statistical significance (P <0.05). Conclusions Budesonide combined with salbutamol and oxytocin-driven therapy in children with asthmatic pneumonia can effectively relieve the phlegm blockage, improve clinical symptoms and shorten the course of disease in children with definite curative effect, which is worthy of clinical application.